Contact
Please use this form to send email to PR contact of this press release:
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
TO:
Please use this form to send email to PR contact of this press release:
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
TO: